Clinical Trials · NCT07059377
Semaglutide for Smoking Cessation in Patients With Diabetes
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Ottawa Heart Institute Research Corporation
- Enrollment
- 100
- Start date
- Feb 2026
- Locations
- 1 site, Canada
- Primary endpoint
- Project success